Anne-Fleur van der Paardt
- Evaluation of macrolides for possible use against multidrug-resistant Mycobacterium tuberculosisBy Anne-Fleur van der Paardt, Bob Wilffert, Onno W. Akkerman, Wiel C.M. de Lange, Dick van Soolingen, Bhanu Sinha, Tjip S. van der Werf, Jos G.W. Kosterink and Jan-Willem C. AlffenaarArticle | Published in 2015 in European Respiratory JournalAnne-Fleur van der Paardt1University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy and Pharmacology, Groningen, The NetherlandsBob Wilffert1University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands2University of Groningen, Dept of Pharmacy, Section Pharmacotherapy and Pharmaceutical Care, Groningen, The NetherlandsOnno W. Akkerman3University of Groningen, University Medical Center Groningen, Tuberculosis Center Beatrixoord, Haren, The Netherlands4University of Groningen, University Medical Center Groningen, Dept of Pulmonary Diseases and Tuberculosis, Groningen, The NetherlandsWiel C.M. de Lange3University of Groningen, University Medical Center Groningen, Tuberculosis Center Beatrixoord, Haren, The Netherlands4University of Groningen, University Medical Center Groningen, Dept of Pulmonary Diseases and Tuberculosis, Groningen, The NetherlandsDick van Soolingen5National Tuberculosis Reference Laboratory, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands6Radboud University Nijmegen Medical Center, Depts of Pulmonary Diseases and Medical Microbiology, Nijmegen, The NetherlandsBhanu Sinha7University of Groningen, University Medical Center Groningen, Dept of Medical Microbiology and Infection Prevention, Groningen, The NetherlandsTjip S. van der Werf4University of Groningen, University Medical Center Groningen, Dept of Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands8University of Groningen, University Medical Center Groningen, Dept of Internal Medicine, Groningen, The NetherlandsJos G.W. Kosterink1University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands2University of Groningen, Dept of Pharmacy, Section Pharmacotherapy and Pharmaceutical Care, Groningen, The NetherlandsJan-Willem C. Alffenaar1University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands
- Evaluation of macrolides for possible use against multidrug-resistant Mycobacterium tuberculosisBy Anne-Fleur van der Paardt, Bob Wilffert, Onno W. Akkerman, Wiel C.M. de Lange, Dick van Soolingen, Bhanu Sinha, Tjip S. van der Werf, Jos G.W. Kosterink and Jan-Willem C. AlffenaarAnne-Fleur van der Paardt1University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy and Pharmacology, Groningen, The NetherlandsBob Wilffert1University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands2University of Groningen, Dept of Pharmacy, Section Pharmacotherapy and Pharmaceutical Care, Groningen, The NetherlandsOnno W. Akkerman3University of Groningen, University Medical Center Groningen, Tuberculosis Center Beatrixoord, Haren, The Netherlands4University of Groningen, University Medical Center Groningen, Dept of Pulmonary Diseases and Tuberculosis, Groningen, The NetherlandsWiel C.M. de Lange3University of Groningen, University Medical Center Groningen, Tuberculosis Center Beatrixoord, Haren, The Netherlands4University of Groningen, University Medical Center Groningen, Dept of Pulmonary Diseases and Tuberculosis, Groningen, The NetherlandsDick van Soolingen5National Tuberculosis Reference Laboratory, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands6Radboud University Nijmegen Medical Center, Depts of Pulmonary Diseases and Medical Microbiology, Nijmegen, The NetherlandsBhanu Sinha7University of Groningen, University Medical Center Groningen, Dept of Medical Microbiology and Infection Prevention, Groningen, The NetherlandsTjip S. van der Werf4University of Groningen, University Medical Center Groningen, Dept of Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands8University of Groningen, University Medical Center Groningen, Dept of Internal Medicine, Groningen, The NetherlandsJos G.W. Kosterink1University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands2University of Groningen, Dept of Pharmacy, Section Pharmacotherapy and Pharmaceutical Care, Groningen, The NetherlandsJan-Willem C. Alffenaar1University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.